Survival rates for babies born extremely prematurely increased between 1995 and 2006, but few improvements in neonatal morbidity occurred despite appropriate interventions. The current study was undertaken to examine the neurologic and developmental outcomes for babies born at less than 27 weeks' gestation in 2006 and to compare the survival and outcomes at 3 years of age with those of babies born at 22 to 25 weeks' gestation in 1995.
EDITORIAL COMMENT
(Historically, the advent of neonatal intensive care units (NICUs) has dramatically lowered the rate of neonatal mortality at low gestational ages. Around the world, in countries without the resources to have NICUs, babies born before 28 weeks' gestation have essentially a 100% rate of mortality. Although we have been able to push the threshold of viability down to 24 and even 23 or 22 weeks of gestation, the long-term morbidity of these neonates has continued to be quite severe and in a large proportion. There continue to be improvements made in NICU care with less aggressive use of high levels of oxygen or ventilation. Thus, the current article from the BMJ, abstracted above, examined the long-term outcomes at 3 years of age in neonates born at 22 to 25 weeks ' gestation in 1995 and 2006. This study found that survival rates between the 2 time periods were improved from 39% to 52% with a great dependence on the specific gestational age (ranging from 7% at 22 weeks up to 66% at 25 weeks). Discouragingly, there was no difference in the rate of severe morbidity in survivors. However, there was an increase in neonates who survived without disability from 23% to 34%. Again, there was a strong relationship between gestational age and the prevalence of moderate or severe impairment (45% of survivors at 22/23 weeks to 25% at 25 weeks). However, much of this difference appeared due to improved survival rates as the rate of survival without severe disability was nonsignificantly increased from 59% to 65%.
Although these data come from the United Kingdom, I think they are incredibly useful for counseling our patients here in the United States where long-term data are hard to come by. Given that about half of the survivors at 22 and 23 weeks' gestation have moderate or severe morbidity, which includes cerebral palsy, blindness, deafness, or cognitive delay, how should patients be counseled? Furthermore, how much autonomy over decisions regarding resuscitation should patients have at various gestational ages? In my conversations with colleagues around the country, nearly all would not even offer/allow resuscitation before 22 weeks. Alternatively, at 26 weeks and beyond, it is often not a parent choice because the neonatal outcomes are deemed to be so good. Between these gestations, I believe a range of practices exist from institutions where resuscitation before 24 weeks is not offered but done begrudgingly if parents inquire, to routine resuscitation of all 23 weeks' gestation neonates.
At my institution, patients undergo informed consent and choose resuscitation versus comfort care at 22 through 25 weeks' gestation. It is rare that we resuscitate a 22-week neonate and very rare that we don't at 25 weeks, but patients are given the opportunity to choose. Seemingly, this is better care than an absolute rule because it allows patients to incorporate their beliefs and preferences regarding this decision. Unfortunately, these patients often have only a short time to make the decision, and it is unclear how well they understand the severity of the long-term outcomes and even how to utilize the varying probabilities to make the decision. It is a very different decision than one about whether to undergo pregnancy termination when diagnosed with a Down syndrome fetus. In that case, patients know for certain that their fetus has Down syndrome, and although there is a range of outcomes, the range is relatively narrow compared with the outcomes at 22 to 25 weeks' gestation. Although the average outcome might be similar, the severe outcomes from 22-to 25-week neonates may be viewed as much worse than Down syndrome, and the survivors without disability have better outcomes than those with Down syndrome. So, not only do patients have to think about preferences toward the outcomes, but also they have to understand and use the probabilities related to the range of outcomes. I think this is an incredibly complex decision, one for which few expectant parents are prepared. Other than providing detailed information and responding to questions, we have little to help them make this monumental decision that can have enormous consequences. Furthermore, in this setting, it is not uncommon for these parents to interact with several different providers, most notably an obstetrician or MFM and a neonatologist. In my practice, I make every effort to do this counseling together to ensure a single message regarding this complicated information.VABC)
